NCT00322439View on ClinicalTrials.gov

Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis

CompletedOBSERVATIONAL

Enrollment

2,511

Participants

Timeline

Start Date

May 1, 2006

Primary Completion Date

December 11, 2012

Study Completion Date

February 8, 2013

Conditions

Psoriasis

Interventions

DRUG

Etanercept

Observational study - no drug administered

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY